Tag: ADE

Apr 19, 2026

• cross-reactivity
• ADE
• neutralisation
• IgG
• IgA
• IgM
• IgG3
• IgG4
• serotype
• E-protein
• NS1
• EDI-II
• EDIII
• flavivirus
• diagnostics
• vaccine
• longitudinal
• antibody-kinetics
• anti-prM
• prM
• structural-antibody
• anti-endothelial
• anti-platelet
• Vietnam
• infection-order

Apr 19, 2026

• secondary-infection
• ADE
• DHF
• DSS
• heterotypic
• cross-reactive-antibodies
• disease-severity
• thrombocytopenia
• PAIgG
• PAIgM
• immune-complex
• DHF-predictor
• anti-prM
• anti-endothelial
• IgG
• isotype-switch
• Vietnam

Apr 19, 2026

• serotype
• DENV-1
• epidemiology
• secondary-infection
• ADE
• Singapore
• Nicaragua
• antibody-kinetics
• anti-prM
• cross-reactivity
• NS1-levels
• viraemia

Apr 19, 2026

• Southeast-Asia
• regional
• endemic
• Thailand
• Singapore
• Philippines
• Vietnam
• Cambodia
• DENV-1
• DENV-2
• DENV-3
• DENV-4
• hyperendemic
• paediatric-dengue
• DHF
• autoimmunity
• PAIgG
• PAIgM
• thrombocytopenia
• anti-platelet
• anti-endothelial
• ADE
• anti-prM
• asymptomatic

Apr 17, 2026

• ADE
• immunopathogenesis
• FcR
• secondary-infection
• severe-dengue
• IGHG1
• plasmablast
• scRNA-seq
• IgG-affinity
• FcgRIIIA
• SPR
• anti-prM
• prM-cleavage
• monocyte
• vaccine-design
• ADE-window
• enhancement-titer
• Katzelnick

Apr 17, 2026

• vaccines
• CYD-TDV
• DENVax
• TAK-003
• TV003
• tetravalent
• live-attenuated
• subunit
• ADE
• seronegative
• phase-III
• correlates-of-protection
• anti-prM
• prM-design
• ADE-risk
• ADE-window
• enhancement-titer
• Katzelnick

Apr 17, 2026

• serotype
• DENV-2
• Asian-genotype
• virulence
• ADE
• secondary-infection
• Cuba
• CNS-invasion
• neuropathogenesis
• anti-platelet
• IgM
• autoantibody-cross-serotype
• anti-prM
• cross-reactivity
• NS3
• salivary-gland-replication

Apr 17, 2026

• prM
• pre-membrane-protein
• structural-protein
• virion-maturation
• ADE
• furin-cleavage
• immature-virion
• cross-reactive
• vaccine-design
• molecular-mimicry
• HSP60

Apr 17, 2026

• Thailand
• Southeast-Asia
• DENFREE
• epidemiology
• cohort
• anti-prM
• monoclonal-antibody
• ADE

Apr 17, 2026

• pathogenesis
• sfRNA
• RIG-I
• TRIM25
• interferon-evasion
• ADE
• OAS
• original-antigenic-sin
• T-cells
• glycocalyx
• cathepsin-L
• heparanase
• MIF
• autophagy
• cytokine-storm
• Th2-skewing
• NS1
• review
• India

Apr 17, 2026

• anti-prM
• ADE
• cross-reactive-antibodies
• neutralisation
• monocyte
• dendritic-cell
• vaccine-design
• prM-cleavage
• monoclonal-antibody
• structural-antibody

Apr 17, 2026

• DHF-pathogenesis
• NS1
• ADE
• sfRNA
• T-cells
• complement
• NLRP3
• anti-prM
• OAS
• genome-variation
• IFN-suppression
• review

Apr 14, 2026

• longitudinal
• antibody-kinetics
• IgG-subclass
• IgA
• IgM
• cross-reactive
• E-protein
• NS1
• EDI-II
• EDIII
• ADE
• Nicaragua
• pediatric
• preprint

Apr 13, 2026

• FcR
• FcgRIIA
• FcgRIIB
• FcgRIIIA
• FcgRIIIB
• IgG-subclass
• affinity
• SPR
• polymorphism
• ADE
• immune-complex
• inhibitory-receptor
• IgG2
• IgG3
• fucosylation
• immunotherapy

Apr 12, 2026

• vaccine
• CYD-TDV
• Dengvaxia
• Sanofi-Pasteur
• ADE
• seronegative
• phase-III
• live-attenuated
• ChimeriVax
• tetravalent

Apr 12, 2026

• review
• disease-primer
• epidemiology
• pathophysiology
• ADE
• NS1
• E-protein
• vaccines
• CYD-TDV
• vector-control
• diagnosis
• clinical-classification
• global-burden
• flavivirus
• TLR4
• thrombocytopenia
• coagulopathy
• vascular-permeability

Apr 12, 2026

• scRNA-seq
• single-cell
• immune-profiling
• asymptomatic
• CD8-T-cells
• NK-cells
• plasmablasts
• ADE
• type-I-interferon
• IL-10
• BCR-repertoire
• TCR-repertoire
• Thailand
• immunopathogenesis

Apr 12, 2026

• autoimmunity
• molecular-mimicry
• NS1
• ADE
• immunopathogenesis
• platelets
• endothelial-cells
• coagulation
• vaccine
• intrinsic-ADE
• IFN-I
• IL-10
• Taiwan
• review